Thomas James Vanden Boom

Title: Thomas James Vanden Boom: Innovator in Recombinant Protein Production

Introduction

Thomas James Vanden Boom is a notable inventor based in Flemington, NJ (US). He has made significant contributions to the field of biotechnology, particularly in the production of recombinant proteins. With a total of 5 patents to his name, Vanden Boom's work has had a substantial impact on medical research and therapeutic applications.

Latest Patents

Vanden Boom's latest patents include innovative compositions and methods for producing a composition that enables mammalian cells to produce recombinant CTLA4-Ig and its variants. His inventions provide methods for mass-producing CTLA4-Ig from these cells and for purifying the protein. Additionally, he has developed methods to analyze the carbohydrate content of CTLA4 molecules, further enhancing the understanding and application of this important protein in therapeutic settings.

Career Highlights

Throughout his career, Vanden Boom has been associated with Bristol-Myers Squibb Company, a leading global biopharmaceutical company. His work at this esteemed organization has allowed him to collaborate with other talented professionals in the field, driving forward innovations in biotechnology.

Collaborations

Some of Vanden Boom's notable coworkers include Kirk J. Leister and Eugene J. Schaefer. Their collaborative efforts have contributed to the advancement of research and development in recombinant protein technologies.

Conclusion

Thomas James Vanden Boom's contributions to the field of biotechnology through his patents and work at Bristol-Myers Squibb Company highlight his role as an influential inventor. His innovations in recombinant protein production continue to pave the way for advancements in medical therapies.